New stock news | Farasis Energy's Hong Kong IPO prospectus invalidated
Shenzhen Yuenxin Energy Storage Technology Co., Ltd. (referred to as Yuenxin Energy) submitted its Hong Kong stock prospectus on January 9, 2026, which expired after 6 months on July 9, 2026, with CICC being its exclusive sponsor.
Shenzhen Yuanxin Energy Storage Technology Co., Ltd. (Yuanxin Energy), whose Hong Kong Stock Exchange prospectus was submitted on January 9, 2026, expired after 6 months on July 9, 2026, with CICC as its exclusive sponsor.
The prospectus shows that Yuanxin Energy was established in 2019 and is a leading global provider of integrated energy storage system (ESS) solutions, dedicated to empowering high-quality energy storage assets worldwide and providing full lifecycle solutions covering all key stages of energy storage projects. The company focuses on the research and development, manufacturing, and sales of energy storage system solutions, serving customers in China and overseas. Its integrated energy storage system solutions have diverse applications, covering large-scale and industrial and commercial energy storage scenarios.
According to Frost & Sullivan data, the company added 1.3 GWh of independent energy storage capacity in the first nine months of 2025, ranking first among global energy storage asset lifecycle solution providers. In 2024, based on energy storage system shipments, the company ranked fifth among global energy storage asset lifecycle solution providers with a shipment volume of 3.7 GWh.
Related Articles

Jinpu Landscape Architecture (301098.SZ) applied to issue shares to specific entities and received approval from the Shenzhen Stock Exchange.

SpaceXAI (SPCX.US) in collaboration with Cursor releases Grok 4.5: focusing on coding and finance missions, launching a new challenge to Anthropic and OpenAI.

Betta Pharmaceuticals(300558.SZ): Publication of clinical research results on postoperative adjuvant therapy with Anlotinib
Jinpu Landscape Architecture (301098.SZ) applied to issue shares to specific entities and received approval from the Shenzhen Stock Exchange.

SpaceXAI (SPCX.US) in collaboration with Cursor releases Grok 4.5: focusing on coding and finance missions, launching a new challenge to Anthropic and OpenAI.

Betta Pharmaceuticals(300558.SZ): Publication of clinical research results on postoperative adjuvant therapy with Anlotinib

RECOMMEND





